Get the Stockscreener App
8.59
2.39%
-0.20
Rxsight Inc stock is traded at $8.59, with a volume of 310.83K.
It is down -2.39% in the last 24 hours and down -2.50% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$8.79
Open:
$8.84
24h Volume:
310.83K
Relative Volume:
0.34
Market Cap:
$351.88M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-10.48
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-0.92%
1M Performance:
-2.50%
6M Performance:
-45.87%
1Y Performance:
-83.21%
1-Day Range:
$8.49
$8.98
1-Week Range:
$8.32
$8.98
52-Week Range:
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
8.60 | 359.65M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
123.50 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.93 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.74 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.84 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.90 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Best data tools to analyze RxSight Inc. stockMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - newser.com
Is RxSight Inc. showing signs of accumulationQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com
Applying Elliott Wave Theory to RxSight Inc.Market Risk Analysis & Daily Profit Focused Screening - newser.com
Can RxSight Inc. stock continue upward trendMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Does RxSight Inc. qualify in momentum factor screening2025 Analyst Calls & Daily Profit Maximizing Trade Tips - newser.com
Y Intercept Hong Kong Ltd Invests $1.43 Million in RxSight, Inc. $RXST - MarketBeat
Will a bounce in RxSight Inc. offer an exit2025 Sector Review & Stock Portfolio Risk Control - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Real time breakdown of RxSight Inc. stock performanceTreasury Yields & Fast Gaining Stock Reports - newser.com
Why RxSight Inc. stock is favored by top institutionsBreakout Watch & Safe Capital Investment Plans - newser.com
Analyzing drawdowns of RxSight Inc. with statistical toolsWatch List & Community Verified Swing Trade Signals - newser.com
Building trade automation scripts for RxSight Inc.Watch List & Consistent Growth Equity Picks - newser.com
Combining price and volume data for RxSight Inc.July 2025 Technicals & Fast Moving Stock Watchlists - newser.com
Will RxSight Inc. stock benefit from commodity pricesBull Run & Low Drawdown Trading Techniques - newser.com
Can you recover from losses in RxSight Inc.Portfolio Risk Report & High Return Trade Opportunity Guides - newser.com
Is RxSight Inc. stock a top momentum playJuly 2025 Levels & Risk Controlled Daily Plans - newser.com
RxSight (RXST) Expected to Announce Earnings on Thursday - MarketBeat
Is RxSight Inc. meeting your algorithmic filter criteriaGap Up & Safe Swing Trade Setups - newser.com
Tools to monitor RxSight Inc. recovery probabilityWeekly Trade Analysis & Low Drawdown Momentum Ideas - newser.com
Why RxSight Inc. stock remains undervaluedTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
Can RxSight Inc. stock resist sector downturnsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
How analysts rate RxSight Inc. stock todayMarket Activity Recap & Stepwise Entry/Exit Trade Alerts - fcp.pa.gov.br
RxSight, Inc. (NASDAQ:RXST) Q2 2025 Earnings Call Transcript - MSN
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.30%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):